ST-503 will be evaluated in a phase 1/2 trial with the first patient scheduled to receive the therapy in the coming months. The Food and Drug Administration (FDA) has granted Fast Track designation to ...
RICHMOND, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Sangamo Therapeutics, Inc. (SGMO), a genomic medicine company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast ...
Please provide your email address to receive an email when new articles are posted on . Multiple diagnostic tools are necessary to assess diabetic peripheral neuropathy in patients. The choice of ...
—This cross-sectional study investigated a possible association between a high GI symptom burden in types 1 and 2 diabetes with the presence of various neuropathies. A high gastrointestinal (GI) ...
A $3.6 million award from the National Institutes of Health will allow neurosurgical, neurology and neuroscience researchers at The Ohio State University Wexner Medical Center and College of Medicine ...
Kristy Townsend, PhD, associate professor in the Department of Neurosurgery at The Ohio State University Wexner Medical Center and College of Medicine. Townsend's research program investigates nervous ...
Please provide your email address to receive an email when new articles are posted on . Patients implanted with a spinal cord simulation system reported less severe pain from baseline to follow up.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results